Extensive-stage small cell lung cancer - Globe Thesis

Keyword [Extensive-stage small cell lung cancer] Result: 21 - 37 \| Page: 2 of 2
21.	Clinical Observation Of Apatinib Combined With Temozolomide In The Treatment Of Relapsed Extensive-stage Small Cell Lung Cancer
22.	Correlation Analysis Of TTF-1 With Efficacy,Side Effects Of First-line Chemotherapy And Prognosis In Patients With Extensive-stage Small Cell Lung Cancer
23.	Albumin/Globulin Ratio In Patients With Extensive-stage Small-cell Lung Cancer
24.	Clinical Study Of PD-L1 Inhibitor Combined With Chemotherapy In The Treatment Of Extensive Stage Small Cell Lung Cancer
25.	The Correlation Between Genetic Mutations And Prognosis In Extensive-stage Small-cell Lung Cancer
26.	Efficacy And Safety Of Apatinib Combined With First-line Chemotherapy In Extensive Stage Small Cell Lung Cancer
27.	The Value Of Dynamic Detection Of The Change Rate Of ProGRP Levels Before And After Chemotherapy In The Evaluation Of The Efficacy And Prognosis Of Extensive-stage Small Cell Lung Cancer
28.	Selection Of Therapeutic Strategies For Extensive Stage Small Cell Lung Cancer
29.	Analysis Of Treatment Patterns And Exploration Of Prognostic Factors For Extensive-stage Small Cell Lung Cance
30.	Radiomics Based Approach To Predict The Risk Of Cachexia On Immunotherapy In Extensive-stage Small Cell Lung Cancer
31.	Clinical Study Of Fuzhengjiannao Ointment On Prevention Of Extensive Stage Small Cell Lung Cancer Brain Metastases Of Qi Deficiency And Phlegm Dampness Syndrome
32.	The Correlation Between Intestinal Flora And The Efficacy Of First-line Immunotherapy Combined With Chemotherapy In Patients With Extensive Small Cell Lung Cancer
33.	Prognostic Significance Of NLR, PLR And Lymphocyte Subsets For First-line PD-1/PD-L1 Inhibitors In The Treatment Of Extensive Stage-small Cell Lung Cancer
34.	Efficacy And Safety Of Anlotinib Combined With Docetaxel In Second-line Treatment Of Extensive Small Cell Lung Cancer
35.	Predictive Value Of Peripheral Blood Parameters For Prognosis Of Extensive Stage Small Cell Lung Cancer Receiving Immunotherapy And Establishment Of Model
36.	Efficacy Analysis Of First-line Immunotherapy In Combination With Chemotherapy Versus Chemotherapy Alone In Extensive-stage Small-cell Lung Cancer: A Single-center Study
37.	Phase Ⅱ Clinical Study Of Anlotinib In Combination With Radiotherapy In The Treatment Of Extensive-Stage Small-Cell Lung Cancer After Failure Of Second Chemotherapy
<<First <Prev Next> Last>> Jump to